Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ono, BioFocus in Discovery Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Ono, BioFocus in Discovery Pact

Aims to discover targets in allergic diseases

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Galapagos NV and Ono Pharmaceutical have signed a collaboration agreement for the discovery of targets in the field of allergic diseases, including atopic dermatitis and bronchial asthma. Galapagos’ service division BioFocus will use its SilenceSelect platform to deliver validated targets to Ono. Ono aims to find modulators for these targets and generate new drug candidates. This marks the second collaboration between the companies. Financial details were not disclosed.
 
“We are delighted with the success of our relationship with Ono,” said Dr. Chris Newton, senior vice president of Galapagos Services and Managing Director BioFocus. “The start of a new collaboration one year after the first one is testament to our target discovery platform and the strength of our partnership.”
 
Kazuhito Kawabata, Ph.D., member of the board of directors, executive officer and executive director, Discovery and Research of Ono, said, “This new project builds upon a novel human primary cell-based assay developed by BioFocus in the field of allergic diseases, an area with significant unmet medical needs. We are excited to apply BioFocus’ target discovery platform to discover and validate novel drug targets.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics